Influvac Sospensione iniettabile

Šalis: Šveicarija

kalba: italų

Šaltinis: Swissmedic (Swiss Agency for Therapeutic Products)

Veiklioji medžiaga:

haemagglutininum influenzae di tipo A (H1N1) (Virus-Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus A/Brisbane/02/2018, IVR-190), haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Kansas/14/2017 (H3N2)-come: reassortant virus A/Kansas/14/2017, NYMC X-327), haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-come: reassortant virus B/Veneto/15/2016 NYMC BX-69A)

Prieinama:

Mylan Pharma GmbH

ATC kodas:

J07BB02

INN (Tarptautinis Pavadinimas):

haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus A/Brisbane/02/2018, IVR-190), haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Kansas/14/2017 (H3N2)-like: reassortant virus A/Kansas/14/2017, NYMC X-327), haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant virus B/Maryland/15/2016 NYMC BX-69A)

Vaisto forma:

Sospensione iniettabile

Sudėtis:

haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus A/Brisbane/02/2018, IVR-190) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Kansas/14/2017 (H3N2)-like: reassortant virus A/Kansas/14/2017, NYMC X-327) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant virus B/Maryland/15/2016 NYMC BX-69A) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: natrii citras dihydricus max. 1 mg, cetrimidum max. 15 µg, formaldehydum max. 10 µg, gentamicini sulfas max. 1 ng, tylosini tartras nihil, hydrocortisonum nihil, polysorbatum 80 nihil, ovalbuminum max. 0.1 µg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml.

Klasė:

B

Farmakoterapinė grupė:

Vaccini

Gydymo sritis:

Immunizzazione attiva contro l'Influenza, che abbiano compiuto il 6. Mese di vita

Leidimo data:

1988-06-24